IL2 and Autoimmunity: As such, we have shown that IL-2 stimulated pSTAT5 activity is enhanced in both mouse and human Tregs when treated with NAEi (Figure 4), and that combination therapy with IL-2 and NAEi can reduce disease severity and arrest disease progression in animal models of autoimmunity (58).